
Azra Health is positioned well to deliver on the natural evolution of how care is being virtualized: initially primary and urgent care, then chronic care, and now specialty care. We are a technology-enabled platform for patients, providers, and payers that enables seamless, connected, and human-centric experiences. Our mission is to create exceptional patient experiences, empower providers, enable first-class care outcomes, and foster transformative improvements in costs to make holistic specialty care accessible and affordable. We will deliver on this mission through our vision of providing compassionate, whole-person, community-based Specialty Care for polychronic Medicare & Medicaid patients.

Azra Health is positioned well to deliver on the natural evolution of how care is being virtualized: initially primary and urgent care, then chronic care, and now specialty care. We are a technology-enabled platform for patients, providers, and payers that enables seamless, connected, and human-centric experiences. Our mission is to create exceptional patient experiences, empower providers, enable first-class care outcomes, and foster transformative improvements in costs to make holistic specialty care accessible and affordable. We will deliver on this mission through our vision of providing compassionate, whole-person, community-based Specialty Care for polychronic Medicare & Medicaid patients.
Founded: February 15, 2022
Headquarters: San Francisco, California, United States
Focus: Technology-enabled, community-based specialty care for polychronic Medicare & Medicaid patients
Stage / Funding: Pre-Seed (most recent round Mar 2023); total funding reported as obfuscated
Social determinants of health (SDOH) and access to community-based specialty care for polychronic Medicare & Medicaid patients.
2022
Health technology / Specialty care
Most recent round listed as Pre-Seed (Mar 2023); reported amounts are obfuscated in available profiles.
“Techstars (lead investor listed for Pre-Seed); additional investors listed in profiles include Sopris Capital Associates and FCA Venture Partners”